Linkerbot targets $6B valuation after Series B+ robotic hand funding

Linkerbot sits at the intersection of two powerful trends: humanoid robotics and ultra‑dexterous manipulation. Owning more than 80% of the market for high degree‑of‑freedom robotic hands gives it unusual leverage over the embodied side of the AI stack. If humanoid robots are to move from demos to real industrial use, hands that can thread needles, handle deformable objects and operate tools are essential—and that’s exactly the niche Linkerbot is racing to dominate. ([investing.com](https://www.investing.com/news/stock-market-news/exclusivechina-robothandbuilding-unicorn-linkerbot-targets-6-billion-valuation-4654932))

From an AGI perspective, this matters because intelligence isn’t just prediction; it’s acting in the world. As labs experiment with agentic models controlling physical systems, companies like Linkerbot provide the hardware substrate those agents will inhabit. The company’s plan to double output toward 10,000 hands a month suggests a near‑term flood of highly capable end‑effectors into labs and factories, which will accelerate data collection for manipulation and open more real‑world deployment experiments.

Competitively, the investor mix—Ant Group, HongShan, and state‑linked funds—shows China treating dexterous robotics as a strategic capability. That places pressure on Western robotics startups and on big tech players investing in humanoids (Tesla, Figure, Agility) to secure their own supply of advanced hands or vertically integrate.